Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02728830
Title A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Stephanie Gaillard, M.D.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field